Private healthcare market in Czech Republic 2018

Market analysis and development forecasts for 2018-2023

View Leaflet

Industry Report

Private healthcare market in Czech Republic 2018

Market analysis and development forecasts for 2018-2023

Product details

Price:

1 200

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Private healthcare market in Czech Republic 2018

Market analysis and development forecasts for 2018-2023

View Leaflet

The report compares value, growth and available business opportunities in the private hospital, private health insurance and medical subscriptions segments of the private healthcare market in the Czech Republic. The analysis explores the impacts of new regulations, practices surrounding medical tourism and the size and value of the private sector. It includes profiles of the market leaders which reveal the scope of operations, financial outlooks and plans for new expansions in the future.

Subscription: 12 months
Publication date: September 2016
Other versions: Polish
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharma
Country: Poland
Pages: 349

Do you need assistance?

Phone: +48 12 340 51 30

Email: info@pmrcr.com

Description

Description

This analysis supplies comprehensive coverage of the recent development and forthcoming opportunities in the private healthcare industry in the Czech Republic. It studies the progress of top companies engaged in the provision of private health insurance, medical subscription plans and medical services at the country’s private hospitals and other facilities. Readers will learn about the current value and structure of this market and will benefit from forecasts for market development from 2018 to 2023.

 


What is the content of the report?

  • Value and recent growth of the entire private healthcare market in the Czech Republic
  • Development forecasts for the market from 2018 until 2023
  • Analysis for the segments of private hospitals, private health insurances and medical subscriptions
  • Leading companies in each market segment – financial results, scope of current activity and planned expansions
  • Recent investments that have influenced the private healthcare market 
  • Possible opportunities for business investments in each segment
  • Impact of regulations, medical tourism and key trends on this market
  • Consumer behaviour and social trends
  • Predicted significant changes to the regulatory landscape. 

Who benefits from the analysis?

This report was compiled for use by managers and experts responsible for business development, sales and the marketing of …

  • Private healthcare services providers operating in the Czech Republic
  • Business engaged in the private health insurance, medical subscription and private hospital activity in the Czech Republic or Central Europe
  • Providers of services, drugs and medical equipment for health care
  • Financial institutions, banks, trade organisations interested in this market and region
  • Market analysts, business consultants and research professionals.

Why to buy the report?

It is recommended to reach for this document when…

  • Building a corporate growth strategy
  • Conducting research on the competition
  • Keeping current with news and events in the healthcare market in the Czech Republic 
  • Starting a new private healthcare enterprise in the country
  • Assessing growth potential of this market before making an investment decision or budgeting.
Table of Contents

Table of Contents

  • Key reforms and trends
  • General characteristics and market value
  • Largest players and their profiles
    • Other private medical services companies
    • Recent and planned investments
  • Other private medical services companies
  • Recent and planned investments
  • Medical subscriptions market
  • Private health insurance market
    • Overview
    • Market value
    • Largest players and their profiles
  • Overview
  • Market value
  • Largest players and their profiles
  • Private hospitals
    • Major trends and events and their effect on the private hospital market
    • Number and characteristics of establishments
    • Recent and planned investments in non-public hospitals
    • Largest players and their profiles
  • Major trends and events and their effect on the private hospital market
  • Number and characteristics of establishments
  • Recent and planned investments in non-public hospitals
  • Largest players and their profiles
  • Consumer behaviour and social trends
    • Medical tourism
  • Medical tourism
Graphs and Tables

Graphs and Tables

List of tables

  • Main past trends and events and their effect on the private healthcare market in the Czech Republic, 2016-2017
  • M&A on the private healthcare market in the Czech Republic, 2016-2017
  • Level of satisfaction with healthcare system in the Czech Republic (%), 2015-2016
  • Assessment of problems in various areas of country’s healthcare system among Czechs (%), 2016
  • Anticipated trends and events and their effect on the private healthcare market in the Czech Republic, 2018-2023
  • General information pertaining to Agel in the Czech Republic, 2017
  • Structure of Agel Group healthcare companies in the Czech Republic, 2017
  • Agel’s consolidated revenue and net profit (€ m) and change (%), 2012-2016
  • Financial results of selected Agel Group’s companies in the Czech Republic (€ m), 2011-2016
  • General information pertaining to EUC in the Czech Republic, 2017
  • Structure of EUC in the Czech Republic, 2017
  • Structure of EUC Group in the Czech Republic (%), subsidiaries, 2017
  • Financial results of selected EUC Group’s companies in the Czech Republic (€ m), 2011-2016
  • General information pertaining to FutureLife in the Czech Republic, 2017
  • Structure of FutureLife in the Czech Republic and Slovakia, 2017
  • Financial results of selected Hartenberg Holding’s companies in the Czech Republic (€ m), 2010-2015
  • Structure of Zavalianis’ Group in the Czech Republic, 2017
  • General information pertaining to Multiscan in the Czech Republic, 2017
  • General information pertaining to Medicon in the Czech Republic, 2017
  • Structure of Medicon in the Czech Republic, 2017
  • Structure of Medicon Group in the Czech Republic, daughter companies, 2017
  • Financial results of selected Medicon Group’s companies in the Czech Republic (€ m), 2011-2015
  • Financial results of selected Pronatal Group’s companies (€ m), 2016
  • General information pertaining to MediClinic in the Czech Republic, 2017
  • Structure of MediClinic in the Czech Republic, 2017
  • Financial results of selected MediClinic Group’s companies in the Czech Republic (€ m), 2011-2016
  • General information pertaining to Medireco in the Czech Republic, 2017
  • Structure of Medireco in the Czech Republic, 2017
  • Financial results of selected Medireco’s companies in the Czech Republic (€ m), 2011-2016
  • Selected other major private medical services companies in the Czech Republic, 2017
  • Sales revenues and net profit/loss (m €) of selected other major private medical companies in the Czech Republic, 2012-2016
  • Corporate spending on healthcare in the Czech Republic (CZK m) and change (%, y-o-y), 2008-2013 and 2015
  • Prescribed contractual premiums from private health insurance of selected largest players in the Czech Republic (€ m), 2012-2016
  • General information pertaining to BNP Paribas Cardif in the Czech Republic, 2017
  • General information pertaining to CP Zdravi in the Czech Republic, 2017
  • General information pertaining to Pojistovna Ceske sporitelny in the Czech Republic, 2017
  • General information pertaining to Uniqa in the Czech Republic, 2017
  • General information pertaining to Pojistovna VZP in the Czech Republic, 2017
  • Other major private insurers which offer health insurance in the Czech Republic, 2017
  • Main past trends and events and their effect on the private hospital market in the Czech Republic, 2016-2017
  • Expenditures and revenues of Czech hospitals (CZK m), 2016
  • Acquisitions on the private hospital market in the Czech Republic, 2016-2017
  • Anticipated trends and events and their effect on the private hospital market in the Czech Republic, 2018-2023
  • General information pertaining to Krajska Zdravotni in the Czech Republic, 2017
  • Key information about hospitals operated by Krajska Zdravotni in the Czech Republic, 2017
  • Basic data on activity of Krajska Zdravotni hospitals in the Czech Republic, 2016
  • Krajska Zdravotni revenues and net profit/loss in the Czech Republic (€ m), 2011-2016
  • General information pertaining to Vamed Mediterra in the Czech Republic, 2017
  • Key information about hospitals operated by Vamed Mediterra in the Czech Republic, 2017
  • Financial results of selected Vamed Mediterra hospitals in the Czech Republic (€ m), 2011-2016
  • General information pertaining to Penta Hospitals in the Czech Republic, 2017
  • Key information about hospitals operated by Penta in the Czech Republic, 2017
  • Financial results of selected Penta hospitals in the Czech Republic (€ m), 2011-2016
  • Selected largest non-public hospitals in the Czech Republic and their characteristics, 2017
  • Financial results of selected other largest hospitals in the Czech Republic (€ m), 2011-2016
  • Number of foreigners treated at hospitals in the Czech Republic, 2010-2016


List of graphs

 

  • Opinions of Czechs on the introduction of patient co-payments in the country (%), August 2017
  • Value (€ m) and change (%) of the private medical services market in the Czech Republic, 2011-2023
  • EUC’s sales revenue and y-o-y change in the Czech Republic (€ m), 2015-2016
  • Multiscan’s operating revenue and net profit in the Czech Republic (€ m), 2008-2016
  • Prescribed contractual premiums from private health insurance in the Czech Republic (€ m) and change (%), 2007-2016
  • Market share of selected largest players in the private health insurance market in the Czech Republic (%), 2016
  • BNP Paribas Cardif’s private health insurance prescribed premiums in the Czech Republic (€ m) and change (%), 2010-2016
  • Zdravi’s private health insurance prescribed premiums in the Czech Republic (€ m) and change (%), 2010-2016
  • Gross premium written and claims in the area of non-life insurance of Zdravi in the Czech Republic (€ m), 2011-2016
  • Pojistovna Ceske sporitelny’s private health insurance prescribed premiums in the Czech Republic (€ m) and change (%), 2010-2016
  • Gross premium written and claims in the area of private health insurance of Uniqa in the Czech Republic (€ m), 2012-2016
  • Share of private health insurance as a proportion of total written premiums collected by Uniqa in the Czech Republic (%), 2012-2016
  • Number of claims reported as a proportion of the arena of private health insurance of Uniqa in the Czech Republic, 2012-2016
  • Pojistovna VZP’s private health insurance prescribed premiums in the Czech Republic (€ m) and change (%), 2010-2016
  • Number of foreigners treated at hospitals in the Czech Republic, by country of origin (%), 2016
  • Gross premium written and claims in the arena of accident and health insurance of Pojistovna VZP in the Czech Republic (€ m), 2011-2016

 

Infographic

Infographic

Product details

Price:

1 200

Select languages:

Choose language

You don't have to wait. The content will be accessible online at the My PMR account.

Subscription: 12 months
Publication date: January 2018
Delivery: Online with easy export (PDF, PPT, XLS, DOC)
Sector: Pharma & Healthcare
Country: Czech republic

Do you need assistance?

Phone: +48 12 340 51 30

Email: support@pmrcorporate.com

Clients' Testimonials

 We are a long-standing subscriber of PMR’s information services, and specifically its pharmaceutical and healthcare market news bulletins.

We appreciate the reliability of the information provided,and the high standards of data analysis offered by PMR.    

President

PHOENIX Pharma Polska Sp. z o. o

I have been using PMR reports in my daily work for over 3 years. They are a source of consolidated knowledge based on the relevant indicators. At the same time I value our cooperation as an expert in the Health Care market in Poland. Your forecasts are important to us when working on marketing and promotional strategies.

Head of Sales and Marketing

Roche Diagnostic Polska Sp. z o.o.

Standard - license option entitles Client to make use of the product for a maximum of 2 persons indicated in the purchase process

Standard Plus - license option entitles Client to make use of the product for between 3 and 9 persons indicated in the purchase process

Corporate - license option entitles Client to make use of the product for between 10 and an unlimited number of persons indicated in the purchase process